These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7486159)

  • 41. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine.
    Allan DR; Penner SB; Smyth DD
    Br J Pharmacol; 1996 Jan; 117(1):29-34. PubMed ID: 8825339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
    Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
    Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells.
    Langin D; Paris H; Dauzats M; Lafontan M
    Eur J Pharmacol; 1990 Apr; 188(4-5):261-72. PubMed ID: 1973120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antinociceptive properties of intrathecal dexmedetomidine in rats.
    Fisher B; Zornow MH; Yaksh TL; Peterson BM
    Eur J Pharmacol; 1991 Jan; 192(2):221-5. PubMed ID: 1674472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of imidazoline sites in rabbit kidney.
    Hamilton CA; Jardine E; Reid JL
    Eur J Pharmacol; 1993 Oct; 243(1):95-7. PubMed ID: 7902815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test.
    Durcan MJ; Lister RG; Linnoila M
    Neuropharmacology; 1989 Mar; 28(3):275-81. PubMed ID: 2566945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imidazoline binding sites in fat cells. Localization and pharmacologic differentiation from alpha 2-adrenergic receptors.
    Lafontan M; Langin D; Portillo M; Paris H
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):72S-79S. PubMed ID: 1350731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors.
    Poree LR; Guo TZ; Kingery WS; Maze M
    Anesth Analg; 1998 Oct; 87(4):941-8. PubMed ID: 9768799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular actions of medetomidine and their reversal by atipamezole.
    Savola JM
    Acta Vet Scand Suppl; 1989; 85():39-47. PubMed ID: 2571276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Landiolol decreases a dysrhythmogenic dose of epinephrine in dogs during halothane anesthesia.
    Takahashi S; Fujii Y; Inomata S; Miyabe M; Toyooka H
    Can J Anaesth; 1999 Jun; 46(6):599-604. PubMed ID: 10391611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analgesic potency of alpha adrenergic agents after systemic administration in amphibians.
    Brenner GM; Klopp AJ; Deason LL; Stevens CW
    J Pharmacol Exp Ther; 1994 Aug; 270(2):540-5. PubMed ID: 7915313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors.
    Tibiriça E; Feldman J; Mermet C; Monassier L; Gonon F; Bousquet P
    Eur J Pharmacol; 1991 Dec; 209(3):213-21. PubMed ID: 1686768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.
    Olmos G; Miralles A; Barturen F; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1000-7. PubMed ID: 1545372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Alpha 2-agonists in anesthesia and intensive medicine].
    Bischoff P; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Feb; 28(1):2-12. PubMed ID: 8096770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.